1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About CVRx Inc



Totality of Evidence from BeAT-HF Study Shows CVRx’s Barostim Provides Long-term Benefits for Patients with Heart Failure
Mar 21, 2023 15:02pm

MINNEAPOLIS, March 21, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc . (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative extravascular implantable neuromodulation device for patients with cardiovascular diseases, announced detailed preliminary results of the post-market phase of the BeAT-HF trial at the second annual Technology and Heart Failure (HF) Therapeutics (THT) conference on Tuesday, March 21, 2023. These results are being presented by Dr. Michael Zile, Professor of Cardiology at the Medical University of South Carolina (MUSC).

CVRX: Price Response For Barostim Trial Equals Uncertainty On Equity Curve (NASDAQ:CVRX)
Feb 24, 2023 15:09pm

Heavy selloff following top-line data from the BeAT-HF trial, that failed ot meet primary endpoint. Still, there was numerous secondary data that was positive.

Source:Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Notifies CVRx, Inc. (CVRX) Investors of Investigation
Feb 23, 2023 17:01pm

NEW YORK--(BUSINESS WIRE)---- $CVRX #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of investors of CVRx, Inc. (“CVRx” or “the Company”) (NASDAQ: CVRX). CVRx investors are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: The investigation concerns whether CVRx violated federal securities laws. On February 21, 2023, CVRx announced that its BeAT-HF post-market phase trial for

Source:Business Wire
Morning Stocks Trending Alert: CVRx, Inc. (NASDAQ:CVRX), Almaden Minerals Ltd. (AMEX:AAU)
Feb 23, 2023 04:01am

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Morning Stocks Trending Alert: CVRx, Inc. (NASDAQ:CVRX), Almaden Minerals Ltd. (AMEX:AAU) appeared first on Stocks Equity .

Source:Stock Equity
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
Feb 23, 2023 00:57am

NEW YORK, Feb. 22, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. ("CVRx" or the "Company") (NYSE: CVRX). Such investors are advised to contact Robert S. Willoughby at or 888-476-6529, ext. 7980. The investigation…

Source:PR Newswire
Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday''s Mid-Day Session
Feb 22, 2023 18:10pm

Gainers Windtree Therapeutics Inc (NASDAQ: WINT ) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous Formulation For The Treatment Of Acute Heart Failure." ECARX Holdings Inc. (NASDAQ: ECX ) gained 68% to $5.71. Terran Orbital Corporation (NYSE: LLAP ) surged 52% to $2.60 after the company annonced it has been awareded a $2.4 billion contract to design, build, and deploy 300 satellites for Rivada Space Networks. Hoth Therapeutics Inc (NASDAQ: HOTH ) shares rose 34.3% to $2.6613 after dropping over 9% on Tuesday. Hoth Therapeutics recently entered into a service agreement with Shareholder Intelligence Services to investigate and report on potential illegal naked short selling activities of its stock. Intuitive Machines, Inc. (NASDAQ: LUNR ) jumped 27.4% to $48.26. Usio, Inc. (NASDAQ: USIO ) rose 26.3% to $2.21. Berry Corporation (NASDAQ: BRY ) gained 19.9% to $10.56 after reporting better-than-expected Q4 results.

GMBL, TILE and LSDI among mid-day movers
Feb 22, 2023 18:07pm

Gainers: Intuitive Machines LUNR +219%.ECARX ECX +115%.Terran Orbital LLAP +86%.Windtree (WINT) +58%.CVRx CVRX +42%.Ocean Biomedical (OCEA) +35%.Legato Merger (SLND) +26%.TROOPS…

Source:Seeking Alpha
Hoth, CVRx top healthcare gainers; Quoin, Chemomab among losers
Feb 22, 2023 15:04pm

Hoth Therapeutics (HOTH) +35%. CVRx (CVRX) +21%. Quoin Pharmaceuticals (QNRX) -41%. Chemomab Therapeutics (CMMB) -12%.

Source:Seeking Alpha
CVRx Inc PT Lowered to $15 at Lake Street Capital Markets
Feb 22, 2023 14:30pm
CVRx Nosedives after Heart Treatment Trial Fails
Feb 21, 2023 20:06pm

A failed test is sometimes all it takes to send a stock diving, especially with healthcare stocks. For CVRx (NASDAQ:CVRX), a failed test meant a 60…

Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday''s Mid-Day Session
Feb 21, 2023 19:07pm

Gainers Arbe Robotics Ltd. (NASDAQ: ARBE ) gained … Full story available on

Ambrx, Meihua top healthcare gainers; Aileron, CVRx lead losers'' pack
Feb 21, 2023 15:01pm

Ambrx Biopharma (AMAM) +35%. Meihua International Medical Technologies (MHUA) +27%. Aileron Therapeutics (ALRN) -35%. CVRx (CVRX) -29%.

Source:Seeking Alpha
CVRx crashes 34% as trial for heart failure therapy fails
Feb 21, 2023 14:16pm

CVRx (CVRX) lost ~34% pre-market Tuesday after announcing that its post-market phase trial for FDA-cleared heart failure therapy Barostim did not reach main goal. Read the full story here.

Source:Seeking Alpha
CVRx says BeAT-HF trial did not reach statistical significance on the primary endpoint
Feb 21, 2023 12:13pm
CVRx Inc PT Raised to $20 at Piper Sandler
Feb 10, 2023 11:33am
Lake Street Capital Markets Starts CVRx Inc at Buy
Jan 31, 2023 13:41pm
Indices - JPMorgan Chase & Co. Raises CVRx Price Target to $18.00
Jan 29, 2023 07:37am

CVRx had its target price upped by research analysts at JPMorgan Chase & Co. from $17.00 to $18.00 in a research report issued on Friday, Benzinga reports. The firm presently…

Source:Business Mag
CVRx Inc. (NASDAQ:CVRX) Has Recovered 68.9% So Far, But Another -48.75% Loss Cannot Be Ruled Out
Jan 28, 2023 17:00pm

In last trading session, CVRx Inc. (NASDAQ:CVRX) saw 0.46 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $14.79 trading at $0.42 or 2.92% at ring of the bell on the day assigns it a market valuation of $295.65M. That closing price of CVRX’s stock is at … CVRx Inc. (NASDAQ:CVRX) Has Recovered 68.9% So Far, But Another -48.75% Loss Cannot Be Ruled Out Read More »

Source:Marketing Sentinel
Inozyme, CVRx top healthcare gainers; Nemaura, Marker among losers
Jan 27, 2023 15:00pm

Inozyme Pharma (INZY) +20%. CVRx (CVRX) +10%. Nemaura Medical NMRD -41%. Marker Therapeutics (MRKR) -11%.

Source:Seeking Alpha
CVRx, Inc. (CVRX) Q4 2022 Earnings Call Transcript
Jan 27, 2023 02:10am

CVRx, Inc. (NASDAQ:NASDAQ:CVRX) Q4 2022 Earnings Conference Call January 26, 2023 5:30 PM ETCompany ParticipantsMike Vallie - Westwicke, ICR CompanyNadim Yared - President and Chief…

Source:Seeking Alpha
CVRx GAAP EPS of -$0.51 beats by $0.05, revenue of $7.18M beats by $0.2M
Jan 26, 2023 21:17pm

CVRx press release (CVRX): Q4 GAAP EPS of -$0.51 beats by $0.05.Revenue of $7.18M (+96.2% Y/Y) beats by $0.2M.Q1 2023 Outlook: The Company expects to report total revenue between…

Source:Seeking Alpha
CVRx Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
Jan 26, 2023 21:15pm

Fourth Quarter 2022 Revenue of $7.2 million, a 96% Increase Over Prior Year Fourth Quarter 2022 Revenue of $7.2 million, a 96% Increase Over Prior Year